MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Omnicell Company Profile (NASDAQ:OMCL)

Consensus Ratings for Omnicell (NASDAQ:OMCL) (?)
Ratings Breakdown: 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $36.00 (7.49% upside)

Analysts' Ratings History for Omnicell (NASDAQ:OMCL)
Show:
DateFirmActionRatingPrice TargetActions
5/2/2016FBR & Co.Reiterated RatingBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016Topeka Capital MarketsLower Price TargetBuy$38.00 -> $37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016Piper JaffrayLower Price TargetOverweight$42.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Benchmark Co.Initiated CoverageBuy$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/1/2015Cowen and CompanyReiterated RatingMarket Perform$37.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/28/2015SidotiUpgradeNeutral -> Buy$41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015OppenheimerLower Price TargetOutperform$44.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015StephensInitiated CoverageOutperform$44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2015Craig HallumReiterated RatingBuy$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for Omnicell (NASDAQ:OMCL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
4/28/2016Q116$0.26$0.35$167.18 million$171.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2016Q415$0.39$0.40$126.89 million$130.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315$0.36$0.36$128.50 million$125.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$0.32$0.28$121.35 million$112.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115$0.23$0.29$112.00 million$16.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2015Q414$0.33$0.39$114.65 million$121.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314$0.31$0.30$106.10 million$112.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q214$0.29$0.30$103.23 million$105.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114$0.24$0.26$97.49 million$101.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q413$0.28$0.29$101.13 million$105.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013Q313$0.28$0.31$94.96 million$94.03 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013$0.25$0.27$92.42 million$93.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013$0.19$0.21$87.20 million$87.11 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013Q4 2012$0.25$0.25$87.31 million$90.16 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012$0.22$0.29ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2012$0.18$0.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012$0.13$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2012$0.16$0.19ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011$0.16$0.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011$0.13$0.15ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2011$0.10$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011$0.12$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Omnicell (NASDAQ:OMCL)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.24$0.24$0.24
Q2 20161$0.21$0.21$0.21
Q3 20161$0.31$0.31$0.31
(Data provided by Zacks Investment Research)
Dividend History for Omnicell (NASDAQ:OMCL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Omnicell (NASDAQ:OMCL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/6/2016Jorge R TaborgaVPSell25,979$33.00$857,307.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016Gary S PetersmeyerDirectorSell6,250$31.22$195,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Dan S JohnstonEVPSell8,850$30.73$271,960.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Jorge R TaborgaVPSell1,933$30.73$59,401.09View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016J Christopher DrewVPSell15,000$31.63$474,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Sara J WhiteDirectorSell2,000$31.76$63,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Robin Gene SeimEVPSell6,407$31.00$198,617.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/26/2016Jorge R TaborgaVPSell23,827$30.00$714,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/26/2016Robin Gene SeimEVPSell767$30.00$23,010.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2016Dan S JohnstonEVPSell8,850$27.41$242,578.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2016Jorge R TaborgaVPSell1,685$27.42$46,202.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2016Randall A. LippsCEOSell40,000$27.81$1,112,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016J Christopher DrewVPSell15,000$27.57$413,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2015Nhat H. NgoVPSell4,069$28.71$116,820.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Dan S. JohnstonVPSell2,500$28.00$70,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015J Christopher DrewVPSell25,000$26.79$669,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2015Dan S. JohnstonVPSell2,700$27.29$73,683.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2015Gary S. PetersmeyerDirectorSell670$31.66$21,212.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Robin Gene SeimCFOSell23,946$35.63$853,195.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Robin Gene SeimCFOSell19,582$37.84$740,982.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2015Nhat H NgoVPSell4,067$38.78$157,718.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015James T JudsonDirectorSell8,032$36.83$295,818.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015Nhat H NgoVPSell6,375$36.80$234,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2015Sara J WhiteDirectorSell4,000$36.25$145,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015Dan S JohnstonVPSell7,715$34.25$264,238.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015J Christopher DrewVPSell25,000$34.62$865,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Dan S JohnstonVPSell6,552$33.29$218,116.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015James T JudsonDirectorSell5,000$31.61$158,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2015Gary S PetersmeyerDirectorSell670$31.31$20,977.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015James T JudsonDirectorSell5,000$32.36$161,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Robin Gene SeimCFOSell1,948$32.36$63,037.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2014Marga Ortigas-WedekindVPSell4,080$32.20$131,376.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Gary S PetersmeyerDirectorSell670$33.25$22,277.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014Nhat H NgoVPSell1,754$32.89$57,689.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014James T JudsonDirectorSell5,000$31.94$159,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Randy D LindholmDirectorSell5,000$31.72$158,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014J Christopher DrewVPSell37,500$31.86$1,194,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014Dan S JohnstonVPSell27,625$31.74$876,817.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014James T JudsonDirectorSell5,000$32.27$161,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Nhat H NgoVPSell2,275$28.00$63,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014James T JudsonDirectorSell5,000$27.02$135,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Jorge R TaborgaVPSell944$26.37$24,893.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Robin Gene SeimCFOSell9,347$26.32$246,013.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014James T JudsonDirectorSell5,000$28.18$140,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Robin Gene SeimCFOSell27,500$28.19$775,225.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014Dan S JohnstonVPSell6,250$28.00$175,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014James T JudsonDirectorSell9,913$27.91$276,671.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2014Robin Gene SeimCFOSell2,442$28.21$68,888.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014James T JudsonDirectorSell5,000$29.28$146,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2014Marga Ortigas-WedekindVPSell2,961$28.17$83,411.37View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/25/2014Nhat H NgoVPSell2,274$28.00$63,672.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2014Nhat H NgoVPSell1,420$27.70$39,334.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2014Nhat H NgoVPSell1,964$26.38$51,810.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Gary S PetersmeyerDirectorSell5,000$26.45$132,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2014Gary PetersmeyerDirectorSell2,000$26.51$53,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014J Christopher DrewVPSell37,500$26.08$978,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2014Dan JohnstonVPSell4,000$25.25$101,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014James JudsonDirectorSell5,000$26.24$131,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2014Nhat NgoVPSell1,002$27.40$27,454.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Marga Ortigas-WedekindVPSell5,880$30.00$176,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Randall LippsCEOSell124,910$29.89$3,733,559.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2013Nhat NgoVPSell1,462$24.43$35,716.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2013Randall LippsCEOSell64,739$24.30$1,573,157.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2013Dan JohnstonVPSell73,419$23.24$1,706,257.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2013Randy LindholmDirectorSell3,587$23.00$82,501.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2013Dan JohnstonVPSell8,000$22.99$183,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2013Robin Gene SeimCFOSell7,664$24.50$187,768.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2013Robin Gene SeimCFOSell9,349$23.76$222,132.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2013James T JudsonDirectorSell5,000$23.66$118,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2013Randall LippsCEOSell68,204$25.00$1,705,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/23/2013Marga Ortigas-WedekindVPSell4,000$25.00$100,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/23/2013Randall LippsCEOSell5,083$25.00$127,075.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013Robin Gene SeimCFOSell27,500$24.35$669,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Randall LippsCEOSell64,453$23.67$1,525,602.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Nhat H NgoVPSell7,362$24.00$176,688.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013James JudsonDirectorSell5,000$22.77$113,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2013James JudsonDirectorSell11,724$22.74$266,603.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013J Christopher DrewVPSell20,000$22.83$456,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2013Donald WegmillerDirectorSell34,976$22.87$799,901.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013Dan JohnstonVPSell8,000$22.92$183,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2013Randall LippsCEOSell5,321$23.00$122,383.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Randall A LippsCEOSell25,000$22.50$562,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013James JudsonDirectorSell5,000$21.00$105,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Nhat H NgoVPSell41,875$21.00$879,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Randall A LippsCEOSell5,080$21.00$106,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013James T JudsonDirectorSell5,000$20.46$102,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Robin Gene SeimCFOSell13,032$20.42$266,113.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/28/2013Marga Ortigas-WedekindVPSell4,545$20.00$90,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/28/2013Randall A LippsCEOSell25,000$20.00$500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2013Nhat H NgoVPSell3,459$19.01$65,755.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2013Randall A LippsCEOSell66,378$19.10$1,267,819.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Randy D LindholmDirectorSell23,901$19.14$457,465.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Robin Gene SeimCFOSell25,000$18.72$468,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Gary S PetersmeyerDirectorSell2,750$18.10$49,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013J Christopher DrewVPSell26,000$18.69$485,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013J Christopher DrewVPSell26,000$18.45$479,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013Sara J WhiteDirectorSell7,200$18.50$133,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2013Dan S JohnstonVPSell8,000$18.44$147,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2012Gary S PetersmeyerDirectorSell1,359$15.17$20,616.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Omnicell (NASDAQ:OMCL)
DateHeadline
06/24/16 05:34 PMOmnicell Incorporated (NASDAQ:OMCL) Short Interest Increased By 16.26% - Engelwood Daily
06/24/16 05:34 PMCovering the Bases on Omnicell, Inc. (NASDAQ:OMCL): Where is the Stock Going? - Press Telegraph
06/24/16 05:34 PMOmnicell, Inc. (NASDAQ:OMCL) Earnings Glance and Target Price Review - Engelwood Daily
06/22/16 10:21 AMStrong Buy Calls Count For Omnicell, Inc. (NASDAQ:OMCL) At 5 - Investor Newswire
06/13/16 03:14 PMOMNICELL, INC Files SEC form 8-K, Change in Directors or Principal Officers -
06/09/16 05:58 PMOmnicell, Inc. (NASDAQ:OMCL) Fundamental Star Rating Report - CML News
06/07/16 08:21 AMCan Omnicell Inc (NASDAQ:OMCL) Continue to Deliver Results? - Street Report
06/06/16 09:18 AMPerformance Review for Omnicell, Inc. (NASDAQ:OMCL) - HNN
06/05/16 05:38 PMNext Weeks Broker Price Targets For Omnicell, Inc. (NASDAQ:OMCL) - Share Trading News
06/03/16 08:31 AMShare Rating Focus on Omnicell, Inc. (NASDAQ:OMCL) - HNN - Share Rating Focus on Omnicell, Inc. (NASDAQ:OMCL)HNNPresently, Wall Street analysts have given a consensus stock rating of 1.33 on shares of Omnicell, Inc. (NASDAQ:OMCL). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research. This consensus number is ...and more »
06/02/16 08:37 AMTarget Price and Stock Performance Rundown for Omnicell, Inc. (NASDAQ:OMCL) - HNN - Target Price and Stock Performance Rundown for Omnicell, Inc. (NASDAQ:OMCL)HNNKeeping an eye on share activity using multiple views may be helpful when tracking stock performance. Equity investors have the ability to track short or long term share performance. During the latest trading session, Omnicell, Inc. (NASDAQ:OMCL ...and more »
05/26/16 07:53 AMTarget Check and Stock Performance Recap Omnicell, Inc. (NASDAQ:OMCL) - Wall Street Hints and News - Target Check and Stock Performance Recap Omnicell, Inc. (NASDAQ:OMCL)Wall Street Hints and NewsIn recent session activity, Omnicell, Inc. (NASDAQ:OMCL) shares have traded -1.14%. Monitoring the stock price relative to moving averages may provide enhanced perspective on share performance. After a recent check, the stock has been recorded $1.15 ...and more »
05/25/16 04:27 PMOMNICELL, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/08/16 05:56 AMOmnicell Inc. (OMCL) is Trading Lower on Unusual Volume for May 05 - Equities.com - Omnicell Inc. (OMCL) is Trading Lower on Unusual Volume for May 05Equities.comOmnicell Inc. (OMCL) experienced unusually high volume on May. 05, as the stock lost 1.92% to a closing price of $31.19. The stock saw 373,735 shares trade hands over the course of the day on 3,566 trades. Given that the stock's average daily volume ...and more »
05/07/16 06:01 AMOmnicell Inc. (OMCL) is Trading Lower on Unusual Volume for May 05 - Omnicell Inc. (OMCL) experienced unusually high volume on May. 05, as the stock lost 1.92% to a closing price of $31.19. The stock saw 373,735 shares trade hands over the course of the day on 3,566 trades. Given that the stock’s average daily volume over ...
05/06/16 03:42 PMOMNICELL, INC Files SEC form 10-Q, Quarterly Report -
05/04/16 05:19 AMOmnicell Inc. (OMCL) is Trading Higher on Unusual Volume for May 02 - Equities.com - Omnicell Inc. (OMCL) is Trading Higher on Unusual Volume for May 02Equities.comOmnicell Inc. (OMCL) experienced unusually high volume on May. 02, as the stock gained 0.16% to a closing price of $31.91. The stock saw 370,182 shares trade hands over the course of the day on 3,753 trades. Given that the stock's average daily volume ...and more »
05/04/16 05:19 AMOmnicell, Inc. (OMCL) - Financial and Strategic SWOT Analysis Review - New Market Study Published - 03.05.2016 12:53:12 - Fast Market Research recommends "Omnicell, Inc. (OMCL) - Financial and Strategic SWOT Analysis Review" from GlobalData, now available (live-PR.com) - Omnicell, Inc. (OMCL) - Financial and Strategic SWOT Analysis Review provides you an ...
05/02/16 12:24 PMOmnicell, Inc. :OMCL-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/02/16 10:05 AMOmnicell (OMCL) Q1 Earnings Top Estimates, Margins Drag -
04/30/16 06:08 AMOmnicell : Deutsche Bank 41st Annual Health Care Conference - MOUNTAIN VIEW, Calif., April 29, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for health care facilities, today announced they will present at the Deutsche Bank ...
04/29/16 05:14 PMEdited Transcript of OMCL earnings conference call or presentation 28-Apr-16 8:30pm GMT -
04/29/16 07:29 AMDeutsche Bank 41st Annual Health Care Conference - [at noodls] - MOUNTAIN VIEW, Calif., April 29, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for health care facilities, today ...
04/28/16 04:47 PMOmnicell reports 1Q loss - [AP] - The Mountain View, California-based company said it had a loss of 1 cent per share. Earnings, adjusted for one-time gains and costs, came to 35 cents per share. The results topped Wall Street expectations. ...
04/28/16 03:30 PMOmnicell Inc Earnings Call scheduled for 4:30 pm ET today -
04/28/16 03:26 PMOmnicell Achieves Record Revenue in the First Quarter 2016 - [at noodls] - MOUNTAIN VIEW, Calif., April 28, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for ...
04/28/16 03:18 PMOMNICELL, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
04/28/16 03:08 PM4:08 pm Omnicell beats by $0.09, beats on revs; guides Q2 EPS below consensus, revs in-line -
04/28/16 06:12 AMOmnicell, Inc. (NASDAQ:OMCL) To Release Earnings On Thursday - Share Trading News - Omnicell, Inc. (NASDAQ:OMCL) To Release Earnings On ThursdayShare Trading NewsThe biggest institutional shareholders in Omnicell, Inc. include Oak Ridge Investments, LLC which owns 3 million shares in the company valued at $78.47 million. BlackRock Fund Advisors is the second biggest holder with 2 million shares currently valued ...
04/28/16 06:12 AMOmnicell, Inc. (NASDAQ:OMCL) Analyst Rating Review - The Post - Omnicell, Inc. (NASDAQ:OMCL) Analyst Rating ReviewThe PostCurrently, there are 5 analysts that have provided ratings for Omnicell, Inc. (NASDAQ:OMCL). 5 have rated the stock a “Strong Buy”, 0 rate it a “Buy”, 1 are putting a Hold rating on the stock, and 0 are recommending “Sell”. Every recommendation can be ...and more »
04/28/16 06:07 AMQ1 2016 Omnicell Inc Earnings Release - After Market Close -
04/27/16 07:11 AMUnityPoint Health® Selects Omnicell Medication Automation, Central Pharmacy and Analytics Solutions to Enhance Patient Safety and Efficiency - [at noodls] - MOUNTAIN VIEW, Calif., April 27, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that UnityPoint Health has awarded the Company a 10-year sole source contract as its provider of medication ...
04/27/16 07:05 AMOmnicell, Inc. (NASDAQ:OMCL) Wall Street Rating in Focus - News Tribune - Omnicell, Inc. (NASDAQ:OMCL) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 5 equity research firms that cover shares of Omnicell, Inc. (NASDAQ:OMCL). Sell ...and more »
04/27/16 07:05 AMOmnicell, Inc. (NASDAQ:OMCL) Share Rating Recap - The Post - Omnicell, Inc. (NASDAQ:OMCL) Share Rating RecapThe PostShares of Omnicell, Inc. (NASDAQ:OMCL) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/25/16 06:36 AMCurrent Price Targets For Omnicell, Inc. (NASDAQ:OMCL) - Risers & Fallers - Current Price Targets For Omnicell, Inc. (NASDAQ:OMCL)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Omnicell, Inc. (NASDAQ:OMCL). The latest broker reports which are currently outstanding on Monday 25th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
04/22/16 06:52 AMCould Omnicell, Inc. Recover After Forming a Bearish Multiple Bottom Pattern? - The Post - Could Omnicell, Inc. Recover After Forming a Bearish Multiple Bottom Pattern?The PostThe stock of Omnicell, Inc. (OMCL) shows a multiple bottoms pattern with $26.80 target or 7.00% below today's $28.82 share price. The 8 months chart pattern indicates high risk for the $1.04 billion company. It was reported on Apr, 22 by Finviz.com.and more »
04/22/16 06:52 AMOmnicell, Inc. (NASDAQ:OMCL) Has Been Given An ABR Of 1.33 - Investor Newswire - Omnicell, Inc. (NASDAQ:OMCL) Has Been Given An ABR Of 1.33Investor NewswireAnalysts have a positive outlook on Omnicell, Inc. (NASDAQ:OMCL) stock. As of 2016-04-21, the stock has been placed an ABR of 1.33. This number comes on a scale of 1 to 5, where one suggests a strong buy call and five indicates Strong Sell. The ABR has ...and more »
04/22/16 06:52 AMStock is down at $28.91 ( OMCL ) Omnicell to Release First Quarter 2016… - Omnicell, Inc. currently has a P/E ratio of 34.55 and market cap is ... Oppenheimer started covering OMCL with an initial rating of “Outperform” and establishing a price target of $44.00. October 31 investment analysts at FBR Capital made no change ...
04/22/16 06:52 AMOmnicell Inc.: Omnicell to Release First Quarter 2016 Earnings Results on April 28th - MOUNTAIN VIEW, Calif., April 21, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, April 28 ...
04/21/16 07:24 AMOmnicell to Release First Quarter 2016 Earnings Results on April 28th - [at noodls] - MOUNTAIN VIEW, Calif., April 21, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will ...
04/20/16 07:25 AMOmnicell, Inc. (NASDAQ:OMCL) Updated Broker Price Targets - Share Trading News - Omnicell, Inc. (NASDAQ:OMCL) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Omnicell, Inc. (NASDAQ:OMCL). The latest reports which are currently in issue on Wednesday 20th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...and more »
04/19/16 07:03 AMTracking Earnings for Omnicell, Inc. (NASDAQ:OMCL) - RiversideGazette.com - Tracking Earnings for Omnicell, Inc. (NASDAQ:OMCL)RiversideGazette.comOmnicell, Inc. (NASDAQ:OMCL) has a current consensus EPS estimate for the quarter of $0.16 based on Street analyst predictions. The company is scheduled to next report earnings information on or around 2016-05-05 for the period ending 2016-03-31.and more »
04/17/16 05:53 AMOmnicell, Inc. (NASDAQ:OMCL) Ratios & Valuation in Focus - Orygun Business News - Omnicell, Inc. (NASDAQ:OMCL) Ratios & Valuation in FocusOrygun Business NewsOmnicell, Inc. (NASDAQ:OMCL) of the Medical sector is a highly scrutinized stock when is comes to the firm's valuation and earnings projections. Using the current price over mean EPS estimate before non-recurring items for the fiscal year, the shares ...and more »
04/14/16 11:23 AMIs Omnicell, Inc. a Sell? The Stock Formed Bearish Multiple Bottom Pattern - RiversideGazette.com - Is Omnicell, Inc. a Sell? The Stock Formed Bearish Multiple Bottom PatternRiversideGazette.comThe stock of Omnicell, Inc. (OMCL) shows a multiple bottoms pattern with $25.97 target or 7.00% below today's $27.92 share price. The 8 months chart pattern indicates high risk for the $1.01 billion company. It was reported on Apr, 14 by Finviz.com.and more »
03/21/16 04:07 PMOMNICELL, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
03/21/16 03:23 PMOmnicell Announces Organizational Realignment to Increase Strategic and Operational Focus - [at noodls] - MOUNTAIN VIEW, Calif., March 21, 2016 /PRNewswire/ -- Omnicell, Inc., (NASDAQ: OMCL), today announced it is realigning its organization to continue its growth strategy of offering differentiated products, ...
03/17/16 03:15 PMOmnicell presents the pro forma financial information related to its acquisition of Aesynt - [PR Newswire] - MOUNTAIN VIEW, Calif., March 17, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today issued a press release ...
03/17/16 03:09 PMOMNICELL, INC Files SEC form 8-K/A, Financial Statements and Exhibits -
03/16/16 07:00 AMOmnicell Launches Pharmacy Locator to Connect Consumers with Pharmacies Supporting Medication Adherence Technology - [PR Newswire] - MOUNTAIN VIEW, Calif., March 16, 2016 /PRNewswire/ -- Omnicell, Inc., (OMCL), today announced the availability of the web-based Find-A-Pharmacy tool, which helps connect consumers and their families with pharmacists committed to improving the health of their patients through better medication adherence. By offering SureMed® by Omnicell® multiple medication adherence blister cards, pharmacists are helping patients greatly reduce the complexities of managing and taking multiple medications daily. Currently over one million people use SureMed to help successfully remain in compliance with physician-recommended therapy.
03/03/16 12:04 PMOMNICELL, INC Financials -
About Omnicell

Omnicell logoOmnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products.

Industry, Sector and Symbol:
  • Sector: Technology
  • Industry: Healthcare Information Services
  • Sub-Industry: Health Care Technology
  • Exchange: NASDAQ
  • Symbol: OMCL
  • CUSIP: 68213N10
Key Metrics:
  • Previous Close: $33.51
  • 50 Day Moving Average: $32.36
  • 200 Day Moving Average: $29.25
  • P/E Ratio: 50.36
  • P/E Growth: 1.30
  • Market Cap: $1.20B
  • Current Quarter EPS Consensus Estimate: $1.56 EPS
Additional Links:
Omnicell (NASDAQ:OMCL) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha